Variable of Interest | All patients N = 617 | Age Category at Diagnosis | p-value | |||
---|---|---|---|---|---|---|
< 61 years N = 106 | 61–70 years N = 307 | 71+ years N = 204 | ||||
Body Mass Index [1st, 3rd quartiles] | 26.3 [24.2, 28.3] | 26.8 [24.8, 28.4] | 26.2 [24.3, 28.4] | 25.8 [23.9, 27.7] | 0.032 | |
Marital Status | Not married | 97 (15.8) | 12 (11.3) | 39 (12.8) | 46 (22.8) | 0.004 |
Married/Co-habiting | 516 (84.2) | 94 (88.7) | 266 (87.2) | 156 (77.2) | ||
Education | Lower | 85 (14.0) | 4 (3.8) | 36 (11.8) | 45 (22.5) | <0.001 |
Secondary | 366 (60.1) | 70 (66.7) | 176 (57.9) | 120 (60.0) | ||
University, higher | 158 (25.9) | 31 (29.5) | 92 (30.3) | 35 (17.5) | ||
Smoking Status | Never | 140 (22.8) | 34 (32.4) | 64 (20.9) | 42 (20.9) | <0.001 |
Former | 399 (65.1) | 48 (45.7) | 209 (68.1) | 142 (70.7) | ||
Current | 74 (12.1) | 23 (21.9) | 34 (11.1) | 17 (8.5) | ||
Currently Employed | No | 512 (85.8) | 56 (52.8) | 274 (90.7) | 182 (96.3) | <0.001 |
Yes | 85 (14.2) | 50 (47.2) | 28 (9.3) | 7 (3.7) | ||
SES (%) | Low | 98 (16.7) | 15 (14.7) | 35 (12.0) | 48 (24.7) | 0.002 |
Medium | 238 (40.5) | 39 (38.2) | 120 (41.1) | 79 (40.7) | ||
High | 252 (42.9) | 48 (47.1) | 137 (46.9) | 67 (34.5) | ||
Gleason Score (%) | 2–6 | 329 (55.0) | 63 (61.8) | 178 (60.1) | 88 (44.0) | 0.003 |
7 | 175 (29.3) | 29 (28.4) | 75 (25.3) | 71 (35.5) | ||
8–10 | 94 (15.7) | 10 (9.8) | 43 (14.5) | 41 (20.5) | ||
Stage of Cancer (%) | I | 292 (47.9) | 57 (54.8) | 154 (50.3) | 81 (40.5) | 0.121 |
II | 208 (34.1) | 34 (32.7) | 102 (33.3) | 72 (36.0) | ||
III | 97 (15.9) | 11 (10.6) | 45 (14.7) | 41 (20.5) | ||
IV | 13 (2.1) | 2 (1.9) | 5 (1.6) | 6 (3.0) | ||
Time since Diagnosis (years, %) | < 2 | 10 (1.8) | 1 (1.0) | 5 (1.7) | 4 (2.2) | <0.001 |
2–4 | 280 (49.0) | 35 (36.1) | 143 (49.7) | 102 (54.8) | ||
4–6 | 272 (47.6) | 54 (55.7) | 139 (48.3) | 79 (42.5) | ||
> 6 | 9 (1.6) | 7 (7.2) | 1 (0.4) | 1 (0.5) | ||
Comorbidities (%) | Heart Condition | 124 (22.5) | 15 (14.7) | 56 (20.4) | 53 (30.3) | 0.006 |
Stroke | 13 (2.5) | 0 (0.0) | 9 (3.4) | 4 (2.6) | 0.174 | |
Hypertension | 207 (37.6) | 35 (34.7) | 106 (37.9) | 66 (38.8) | 0.783 | |
Asthma, Bronchitis, COPD | 71 (13.2) | 7 (7.0) | 40 (14.6) | 24 (14.6) | 0.128 | |
Diabetes | 85 (15.7) | 11 (10.9) | 38 (14.0) | 36 (21.3) | 0.041 | |
Ulcer | 10 (1.9) | 1 (1.0) | 5 (1.9) | 4 (2.5) | 0.681 | |
Kidney Disease | 16 (3.0) | 2 (2.0) | 4 (1.5) | 10 (6.1) | 0.021 | |
Liver Disease | 2 (0.4) | 0 (0.0) | 2 (0.8) | 0 (0.0) | 0.693 | |
Anemia/Blood Condition | 25 (4.7) | 2 (2.0) | 10 (3.8) | 13 (8.2) | 0.040 | |
Thyroid Disease | 14 (2.6) | 2 (2.0) | 4 (1.5) | 8 (4.9) | 0.092 | |
Depression | 42 (8.0) | 12 (11.9) | 20 (7.5) | 10 (6.3) | 0.251 | |
Arthritis | 141 (26.1) | 20 (19.6) | 69 (25.4) | 52 (31.3) | 0.098 | |
Backache | 150 (28.0) | 29 (28.4) | 77 (28.2) | 44 (27.5) | 0.983 | |
Rheumatism | 42 (8.1) | 7 (7.1) | 24 (9.1) | 11 (6.9) | 0.674 | |
Treatment Type (%) | Prostatectomy | 224 (36.7) | 63 (60.0) | 123 (40.5) | 38 (18.8) | <0.001 |
Radiation | 278 (45.5) | 41 (39.1) | 148 (48.7) | 89 (44.1) | 0.204 | |
Hormone Therapy | 126 (20.6) | 15 (14.3) | 54 (17.8) | 57 (28.2) | 0.004 | |
Active Surveillance/Watchful Waiting | 27 (4.4) | 5 (4.8) | 12 (4.0) | 10 (5.0) | 0.850 |